Quanto Agroworld shares are currently trading at ₹63.65 as of September 22, 2026, 02:44 PM IST, representing a 0.01% discount to its initial public offer price of ₹67 per share. The stock made its market debut on September 22, 2026, trading at ₹66.99, but quickly declined to hit the 5% lower circuit from the listing price. The counter has shown 0.0% returns over the past day, month, 3 months, 6 months, 1 year, 3 years, and 5 years. The stock is classified as a Smallcap on the BSE and operates in the Agriculture/Horticulture/Lives Sector.
The company's IPO was subscribed 1.37 times during its subscription period from September 15-17, 2026. The issue comprised a fresh issue of 46.30 lakh equity shares with a face value of ₹10 each, aggregating to ₹31.02 crore at the issue price. The IPO was priced at ₹67 per share and was open for subscription from September 15-17, 2026.
According to reports from Business Standard, the company plans to utilize the IPO proceeds strategically across multiple areas. ₹3.79 crore is allocated for capital expenditure on a distillation plant at Ravalgaon, Maharashtra, ₹15.23 crore for expansion and development of farms, ₹3.63 crore for prepayment or repayment of outstanding borrowings, and up to ₹4.65 crore for general corporate purposes.
As reported by Business Standard, Quanto Agroworld is engaged in the cultivation, processing and supply of medicinal and aromatic plants (MAPs) in India, with lemongrass as its primary crop. The company operates with approximately 424 acres of developed agricultural land under Maharashtra State Farming Corporation and 312.57 acres under development. Its subsidiary, Quanto Agritech, has leased 165.33 acres of private agricultural land. The company operates a distillation facility at Ravalgaon with a certified installed essential oil processing capacity of 11.25 metric tonnes per annum and plans to increase this to 56.25 metric tonnes per annum.
For FY2026, Quanto Agroworld demonstrated strong financial growth across key metrics. According to reports from Business Standard, consolidated sales increased 144.6% to ₹40.35 crore, while profit before tax rose 35.2% to ₹8.41 crore. Profit after tax increased 26.1% to ₹8.38 crore, reflecting the company's operational efficiency and market position in the medicinal and aromatic plants sector.
